May 21, 2019

Today the House Energy and Commerce Committee's Health Subcommittee held a hearing on seven proposals that would require greater transparency for prescription drug prices. During the three hour hearing, Representatives examined seven bills that would require drug compa...

May 20, 2019

Last week, the Minnesota Legislature approved its first ever bill regulating pharmacy benefit managers (PBMs) to ensure that they don't contribute to higher drug costs. A conference committee of members from both the Minnesota House and Senate met and hammered out a co...

May 15, 2019

The behavior of drug manufacturers, especially when they use their power to stifle competition, is a major reason for why prescription drugs are so unaffordable. GlaxoSmithKline, a British multinational pharmaceutical company headquartered in London and worth $30 billi...

May 15, 2019

Judge Richard Leon of the United States District Court for the District of Columbia, who will decide whether CVS Health and Aetna can finalize their $70 billion merger, has picked six witnesses to testify at a hearing next month before he decides whether to approve the...

May 14, 2019

Drug companies have become very adept at manipulating and regulations and gaming the system in order to preserve monopolies and increase drug costs. This has resulted in increasingly unaffordable medicines, and many Americans are now forced to ration their pills, choos...

May 10, 2019

As we have previously mentioned, the pharmacy benefit manager (PBM) market lacks the essential ingredients needed for a competitive market that lowers prices and benefits consumers. Senators have become increasingly concerned about the effect PBMs are having on drug pr...

May 7, 2019

This morning the Senate Judiciary Committee held a hearing on intellectual property and rising prescription drug costs. During a two hour session, the Senators heard from several witnesses how drug companies abuse the patent system and manipulate regulations in order t...

May 7, 2019

A number of consumer groups submitted a letter in support of S. 340, the Creating and Restoring Equal Access to Samples (CREATES) Act. Introduced by Senator Patrick Leahy (D-VT), this bill would stop abusive delaying tactics that brand name companies use to prolong the...

May 3, 2019

Over the past few years, Ohio legislators and executive officials investigated pharmacy benefit managers (PBMs) and found that they were greatly overcharging taxpayers and not lowering drug costs. Now representatives have come up with a proposal to stop this behavior....

May 2, 2019

The House of Representatives and the Senate are both considering measures to lower prescription drug costs, and bills are working their way through various committees. Yet advocates should not lose sight of another important area-state governments. In 2019, states are...

Please reload

Featured Posts